A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) C07H 21/04 (2006.01) C07K 14/705 (2006.01) C12N 15/00 (2006.01) C12N 15/01 (2006.01) C12N 15/09 (2006.01) C12N 15/12 (2006.01) C12N 15/63 (2006.01) C12N 15/70 (2006.01) C12N 15/79 (2006.01) C12P 21/02 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2278771
This invention provides soluble CTLA4 mutant molecules which bind with greater avidity to the CD86 antigen than wildtype CTLA4.
La présente invention concerne des molécules mutantes CTLA4 solubles qui se lient plus avidement à l'antigène CD86 qu'au CTLA4 de type sauvage CTLA4.
Bajorath Jurgen
Linsley Peter S.
Naemura Joseph Roy
Peach Robert James
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Soluble ctla4 mutant molecules and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Soluble ctla4 mutant molecules and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Soluble ctla4 mutant molecules and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2063171